Table 4.
Association between receipt of cancer-directed treatment and quartiles of predicted DS, by disease site and stage †, ‡
| Early Stage NSCLC, % (n = 20,280)* |
Advanced NSCLC, % (n = 31,341)* |
Stage IV ER- Breast Cancer, % (n = 1,519)* |
MDS, % (n = 6,058)* |
|
|---|---|---|---|---|
|
|
||||
| Disability Status (DS) | Received Surgical Resection | Received Chemotherapy within 90 Days of Diagnosis | Received Chemotherapy within 6 Months of Diagnosis | Received ESAs Any Time Post Diagnosis |
| Overall, % | 62.3 | 34.3 | 32.5 | 64.1 |
| Predicted probability poor DS: | ||||
| Q1 (lowest probability poor DS) | 77.3 | 49.1 | 43.1 | 73.7 |
| Q2 | 70.7 | 40.0 | 34.7 | 71.0 |
| Q3 | 60.2 | 30.2 | 33.0 | 66.7 |
| Q4 (highest probability poor DS) | 41.4 | 18.4 | 19.3 | 45.5 |
†
Percentages reported (row %) are the proportion who received treatment by DS.
‡
All comparisons were statistically significant at an alpha level of 0.05 (calculated by χ2 test).
*
Model without interactions, elderly (non-disabled) using 0.11 cut-off for early stage and advanced NSCLC, breast cancer, and MDS.